WVP
ALIM

Worth Venture Partners’s Alimera Sciences ALIM Stock Holding History

Worth Venture Partners’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-556,642
Closed -$2.4M – 129
2023
Q4 		$2.4M Sell
556,642
-37,067
-6% -$125K 1.3% 23
2023
Q3 		$1.84M Buy
+593,709
New +$1.96M 1.09% 31
2022
Q1 		– Sell
-123,947
Closed -$636K – 161
2021
Q4 		$636K Sell
123,947
-3,386
-3% -$16.6K 0.32% 75
2021
Q3 		$537K Hold
127,333
– – 0.24% 88
2021
Q2 		$1.16M Hold
127,333
– – 0.43% 58
2021
Q1 		$1.23M Hold
127,333
– – 0.59% 50
2020
Q4 		$537K Hold
127,333
– – 0.43% 58
2020
Q3 		$619K Hold
127,333
– – 0.51% 47
2020
Q2 		$802K Hold
127,333
– – 0.39% 38
2020
Q1 		$509K Buy
127,333
+28,000
+28% +$170K 0.31% 46
2019
Q4 		$753K Buy
99,333
+71,389
+255% +$426K 0.37% 35
2019
Q3 		$237K Buy
+27,944
New +$254K 0.14% 65

Other funds holding ALIM

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Worth Venture Partners's ALIM Position: Q1 2024 in Review

Worth Venture Partners sold out of Alimera Sciences (ALIM) in Q1 2024, closing a stake of 556,642 shares — an estimated $2.4M sold.

Worth Venture Partners first reported a position in ALIM in Q3 2019 and held it in 12 quarters. The position peaked at $2.4M in Q4 2023. 39 funds tracked by Wall St. Rank hold ALIM as of Q1 2024.

  • Worth Venture Partners reported no remaining Alimera Sciences position as of Q1 2024 after selling out during the quarter.
  • Worth Venture Partners sold 556,642 Alimera Sciences shares in Q1 2024, an estimated $2.4M.
  • Worth Venture Partners first reported a position in Alimera Sciences in Q3 2019 and held it in 12 quarters.
  • Worth Venture Partners's Alimera Sciences position peaked at $2.4M in Q4 2023.
  • 39 funds tracked by Wall St. Rank held Alimera Sciences as of Q1 2024.

Based on Worth Venture Partners's 13F filing for Q1 2024, filed 13 May 2024.